Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
CEVA Inc has a consensus price target of $35.43 based on the ratings of 7 analysts. The high is $40 issued by Rosenblatt on May 8, 2025. The low is $30 issued by Barclays on May 8, 2025. The 3 most-recent analyst ratings were released by Oppenheimer, Barclays, and Rosenblatt on May 9, 2025, May 8, 2025, and May 8, 2025, respectively. With an average price target of $34.33 between Oppenheimer, Barclays, and Rosenblatt, there's an implied 77.89% upside for CEVA Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/09/2025 | Buy Now | 70.98% | Oppenheimer | Martin Yang46% | $40 → $33 | Maintains | Outperform | Get Alert |
05/08/2025 | Buy Now | 55.44% | Barclays | Tavy Rosner43% | $40 → $30 | Maintains | Overweight | Get Alert |
05/08/2025 | Buy Now | 107.25% | Rosenblatt | Kevin Cassidy71% | $40 → $40 | Maintains | Buy | Get Alert |
04/23/2025 | Buy Now | 133.16% | Rosenblatt | Kevin Cassidy71% | $45 → $45 | Maintains | Buy | Get Alert |
02/14/2025 | Buy Now | 133.16% | Rosenblatt | Kevin Cassidy71% | $35 → $45 | Maintains | Buy | Get Alert |
02/14/2025 | Buy Now | 107.25% | Barclays | Tavy Rosner43% | $34 → $40 | Maintains | Overweight | Get Alert |
02/11/2025 | Buy Now | 81.35% | Rosenblatt | Kevin Cassidy71% | $35 → $35 | Maintains | Buy | Get Alert |
12/23/2024 | Buy Now | 81.35% | Northland Capital Markets | Gus Richard62% | $31 → $35 | Maintains | Outperform | Get Alert |
11/08/2024 | Buy Now | 81.35% | Rosenblatt | Kevin Cassidy71% | $28 → $35 | Maintains | Buy | Get Alert |
11/08/2024 | Buy Now | 107.25% | Roth MKM | Suji Desilva75% | $25 → $40 | Maintains | Buy | Get Alert |
10/31/2024 | Buy Now | 45.08% | Rosenblatt | Kevin Cassidy71% | $28 → $28 | Maintains | Buy | Get Alert |
08/08/2024 | Buy Now | 29.53% | Roth MKM | Suji Desilva75% | $20 → $25 | Upgrade | Neutral → Buy | Get Alert |
08/08/2024 | Buy Now | 70.98% | Oppenheimer | Martin Yang46% | $29 → $33 | Maintains | Outperform | Get Alert |
05/10/2024 | Buy Now | 3.63% | Roth MKM | Suji Desilva75% | $25 → $20 | Maintains | Neutral | Get Alert |
02/13/2024 | Buy Now | 45.08% | Rosenblatt | Kevin Cassidy71% | → $28 | Reiterates | Buy → Buy | Get Alert |
12/07/2023 | Buy Now | 45.08% | Rosenblatt | Kevin Cassidy71% | → $28 | Reiterates | Buy → Buy | Get Alert |
08/11/2023 | Buy Now | 50.26% | Barclays | Tavy Rosner43% | $32 → $29 | Maintains | Overweight | Get Alert |
08/10/2023 | Buy Now | 55.44% | Northland Capital Markets | Gus Richard62% | $35 → $30 | Maintains | Outperform | Get Alert |
08/10/2023 | Buy Now | 3.63% | Roth MKM | Suji Desilva75% | $30 → $20 | Downgrade | Buy → Neutral | Get Alert |
08/10/2023 | Buy Now | 81.35% | Rosenblatt | Kevin Cassidy71% | $45 → $35 | Maintains | Buy | Get Alert |
08/10/2023 | Buy Now | 50.26% | Barclays | Tavy Rosner43% | $32 → $29 | Maintains | Overweight | Get Alert |
05/11/2023 | Buy Now | 81.35% | Oppenheimer | Martin Yang46% | $40 → $35 | Maintains | Outperform | Get Alert |
05/11/2023 | Buy Now | 55.44% | Roth MKM | Suji Desilva75% | $40 → $30 | Maintains | Buy | Get Alert |
05/11/2023 | Buy Now | 55.44% | TD Cowen | Matt Ramsay52% | $40 → $30 | Maintains | Outperform | Get Alert |
05/11/2023 | Buy Now | 65.8% | Barclays | Tavy Rosner43% | $41 → $32 | Maintains | Overweight | Get Alert |
02/17/2023 | Buy Now | 112.44% | Barclays | Tavy Rosner43% | $35 → $41 | Maintains | Overweight | Get Alert |
02/16/2023 | Buy Now | 107.25% | Cowen & Co. | Matthew Ramsay73% | $30 → $40 | Maintains | Outperform | Get Alert |
02/16/2023 | Buy Now | 133.16% | Rosenblatt | Kevin Cassidy71% | → $45 | Reiterates | → Buy | Get Alert |
02/14/2023 | Buy Now | 133.16% | Rosenblatt | Kevin Cassidy71% | → $45 | Reiterates | → Buy | Get Alert |
11/11/2022 | Buy Now | 81.35% | Barclays | Tavy Rosner43% | $49 → $35 | Maintains | Overweight | Get Alert |
11/10/2022 | Buy Now | 133.16% | Rosenblatt | Kevin Cassidy71% | $60 → $45 | Maintains | Buy | Get Alert |
The latest price target for CEVA (NASDAQ:CEVA) was reported by Oppenheimer on May 9, 2025. The analyst firm set a price target for $33.00 expecting CEVA to rise to within 12 months (a possible 70.98% upside). 13 analyst firms have reported ratings in the last year.
The latest analyst rating for CEVA (NASDAQ:CEVA) was provided by Oppenheimer, and CEVA maintained their outperform rating.
The last upgrade for CEVA Inc happened on August 8, 2024 when Roth MKM raised their price target to $25. Roth MKM previously had a neutral for CEVA Inc.
The last downgrade for CEVA Inc happened on August 10, 2023 when Roth MKM changed their price target from $30 to $20 for CEVA Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CEVA, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CEVA was filed on May 9, 2025 so you should expect the next rating to be made available sometime around May 9, 2026.
While ratings are subjective and will change, the latest CEVA (CEVA) rating was a maintained with a price target of $40.00 to $33.00. The current price CEVA (CEVA) is trading at is $19.30, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.